ENTERA BIO IS-0000769 (5DT) — Net Asset Quality Index
ENTERA BIO IS-0000769 (5DT) has a Net Asset Quality Index of 37.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €19.48 Million minus total liabilities of €12.21 Million yields net assets of €7.27 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of ENTERA BIO IS-0000769 for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
ENTERA BIO IS-0000769 Net Asset Quality Index Over Time (2021–2025)
This chart shows how ENTERA BIO IS-0000769's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at 37.3%, representing net assets of €7.27 Million against total assets of €19.48 Million EUR. For live market cap and overall valuation, see ENTERA BIO IS-0000769 (5DT) market capitalisation.
Annual Net Asset Quality Index for ENTERA BIO IS-0000769 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for ENTERA BIO IS-0000769 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See 5DT net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 81.9% | €13.10 Million | €15.99 Million | €2.89 Million | ▼ -4.1 pp |
| 2024 | 86.0% | €8.08 Million | €9.39 Million | €1.31 Million | ▼ -2.2 pp |
| 2023 | 88.3% | €10.39 Million | €11.77 Million | €1.38 Million | ▼ -1.3 pp |
| 2022 | 89.5% | €11.75 Million | €13.13 Million | €1.37 Million | ▲ +2.7 pp |
| 2021 | 86.8% | €22.57 Million | €25.99 Million | €3.42 Million | — |